Advisory Services Network, LLC Gilead Sciences, Inc. Transaction History

Advisory Services Network, LLC

$4.9 Billion
Q3 2024

A detailed history of Advisory Services Network, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 62,117 shares of GILD stock, worth $5.75 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

62,117

Previous 62,117 -0.0%

Holding current value

$5.75 Million

Previous $4.26 Million 22.18%

% of portfolio

0.11%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $784,954 - $905,898	-12,430 Reduced 16.67%	62,117 $4.26 Million
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $63,491 - $77,426	-887 Reduced 1.18%	74,547 $5.46 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $856,526 - $971,322	-11,690 Reduced 13.42%	75,434 $6.11 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $612,445 - $668,189	8,283 Added 10.51%	87,124 $6.53 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $281,389 - $320,963	-3,702 Reduced 4.48%	78,841 $6.08 Million
Q1 2023 May 17, 2023	SELL	$77.31 - $88.08 $766,683 - $873,489	-9,917 Reduced 10.73%	82,543 $6.85 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $623,760 - $895,505	-10,009 Reduced 9.77%	92,460 $7.94 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $561,521 - $641,402	9,431 Added 10.14%	102,469 $6.32 Million
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $70,533 - $79,442	-1,222 Reduced 1.3%	93,038 $5.75 Million
Q1 2022 May 23, 2022	BUY	$57.92 - $72.58 $634,166 - $794,678	10,949 Added 13.14%	94,260 $5.6 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $63,906 - $72,535	985 Added 1.2%	83,311 $6.05 Million
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $849,983 - $917,037	12,557 Added 18.0%	82,326 $5.75 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $185,713 - $202,918	2,926 Added 4.38%	69,769 $4.8 Million
Q1 2021 May 24, 2021	BUY	$60.0 - $68.46 $1.51 Million - $1.73 Million	25,201 Added 60.52%	66,843 $4.32 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $189,777 - $216,242	-3,350 Reduced 7.45%	41,642 $2.43 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $289,758 - $364,321	-4,666 Reduced 9.4%	44,992 $2.84 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $1.74 Million - $2.03 Million	-24,121 Reduced 32.69%	49,658 $3.82 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $2.1 Million - $2.69 Million	33,587 Added 83.57%	73,779 $5.52 Million
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $66,672 - $73,337	1,082 Added 2.77%	40,192 $2.61 Million
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $368,683 - $413,435	5,959 Added 17.98%	39,110 $0
Q1 2019 May 20, 2019	BUY	$62.53 - $70.05 $169,581 - $189,975	2,712 Added 8.91%	33,151 $2.16 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $186,644 - $243,557	-3,083 Reduced 9.2%	30,439 $1.9 Million
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $266,872 - $295,476	-3,744 Reduced 10.05%	33,522 $2.59 Million
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $509,307 - $594,088	7,850 Added 26.69%	37,266 $2.91 Million
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $1.02 Million - $1.24 Million	13,986 Added 90.64%	29,416 $0
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $235,862 - $276,868	-3,315 Reduced 17.68%	15,430 $1.11 Million
Q3 2017 Oct 12, 2017	SELL	$72.11 - $85.47 $26,103 - $30,940	-362 Reduced 1.89%	18,745 $1.52 Million
Q2 2017 Aug 17, 2017	BUY	N/A	19,107	19,107 $1.35 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Account

Advisory Services Network, LLC Gilead Sciences, Inc. Transaction History